Envista Holdings (NVST) Capital Expenditures (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Capital Expenditures of $12.5 million in Q2 2026, down 23.31% quarter-over-quarter from $16.3 million in Q4 2025, and up 111.86% on a YoY basis from $5.9 million in Q2 2025.
Envista Holdings (NVST) Capital Expenditures (2018 - 2026) Analysis & Trends
Envista Holdings' Capital Expenditures history runs 9 years deep, the most recent figure standing at $12.5 million for Q2 2026.
- In Q2 2026, Capital Expenditures rose 111.86% year-over-year to $12.5 million; the TTM figure through Apr 2026 stood at $51.9 million (up 80.84% YoY), while the FY2025 annual figure was $45.3 million, up 34.02% from the prior year.
- Capital Expenditures was $12.5 million for Q2 2026 at Envista Holdings, down from $16.3 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $26.9 million in Q3 2022 to a low of $5.9 million in Q1 2025.
- Historically, Capital Expenditures has averaged $13.3 million across 5 years, with a median of $12.3 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures soared 138.55% in 2022, then plunged 59.78% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $16.9 million in 2022, then sank by 51.48% to $8.2 million in 2023, then climbed by 4.88% to $8.6 million in 2024, then jumped by 89.53% to $16.3 million in 2025, then decreased by 23.31% to $12.5 million in 2026.
- The last three Capital Expenditures figures came in at $12.5 million (Q2 2026), $16.3 million (Q4 2025), and $10.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 103.30 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 125.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 33.65 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 26.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 84.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 30.79 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 137.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | 12.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 12.50 Mn |
| Apr 3, 2026 | 12.50 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Dec 31, 2025 | 16.30 Mn |
| Sep 26, 2025 | 10.80 Mn |
| Sep 26, 2025 | 10.80 Mn |
| Jun 27, 2025 | 12.30 Mn |
| Jun 27, 2025 | 12.30 Mn |
| Mar 28, 2025 | 5.90 Mn |
| Mar 28, 2025 | 5.90 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Dec 31, 2024 | 8.60 Mn |
| Sep 27, 2024 | 7.40 Mn |
| Sep 27, 2024 | 7.40 Mn |
| Jun 28, 2024 | 6.80 Mn |
| Jun 28, 2024 | 6.80 Mn |
| Mar 29, 2024 | 11.00 Mn |
| Mar 29, 2024 | 11.00 Mn |
| Dec 31, 2023 | 8.20 Mn |
| Dec 31, 2023 | 8.20 Mn |